Brief description of the Multiple Risk Factor Intervention Trial

Area of Science:

• Cardiovascular disease prevention
• Public health interventions
• Clinical trial design

Background:

• Coronary heart disease (CHD) posed a significant public health challenge.
• Previous trials focused on single risk factors, prompting interest in multifactorial approaches.
• The Multiple Risk Factor Intervention Trial (MRFIT) was conceived as a comprehensive CHD prevention strategy.

Purpose of the Study:

• To determine if reducing elevated serum cholesterol, diastolic blood pressure, and cigarette smoking lowers CHD mortality.
• To evaluate the effectiveness of a special intervention program compared to usual care.
• To assess the impact of a multifactorial risk reduction strategy on cardiovascular outcomes.

Main Methods:

• A randomized, primary prevention trial involving 12,866 men aged 35-57 with at least one risk factor.
• Participants were assigned to either a special intervention (SI) group or usual care (UC) group.
• The SI group received intensive counseling on diet, hypertension management, and smoking cessation; UC group received standard care and information.

Main Results:

• The study followed participants for 6-8 years, monitoring risk factor levels and mortality.
• Detailed data on variables measured at each visit were collected.
• Major mortality results were analyzed to assess the intervention's impact on coronary heart disease deaths.

Conclusions:

• The MRFIT trial provided crucial insights into the feasibility and outcomes of multifactorial risk reduction for CHD.
• Findings informed subsequent strategies for cardiovascular disease prevention.
• The trial design and results contributed significantly to the understanding of CHD etiology and management.